FCC ID VO9-ACI2PAN9028
IVD for monitoring blood glucose. (BGM)
by Roche Diagnostics GmbH
Grantee Code: VO9 Product Code: ACI2PAN9028
Latest application date: 2026-07-24
FCC ID Device Details
| FCC ID | VO9-ACI2PAN9028 |
|---|---|
| Mirrors | fcc.id | gov | fccid.ai |
| Grantee Code | VO9 |
| Product Code | ACI2PAN9028 |
| Applicant Business | Roche Diagnostics GmbH 🇩🇪 |
| Related Domains |  roche.com  wolterskluwer.com |
| Equipment Class | IVD for monitoring blood glucose. (BGM) |
| Test Firm | cetecom advanced GmbH |
Operating Frequencies
| Frequency Range | Application Purpose | Final Action Date |
|---|---|---|
| 2412-2462 MHz | Original Equipment | 2026-07-24 |
| 5180-5240 MHz | Original Equipment | 2026-07-24 |
Exhibits
| Document | Type | Available | File |
|---|---|---|---|
| Users_Manual | Users Manual | 2026-07-24 | PDF 3.1 MB |
| Internal_Photos | Internal Photos | 2026-07-24 | PDF 1.2 MB |
| Internal_Photos_module | Internal Photos | 2026-07-24 | PDF 572.2 KB |
| External_Photos | External Photos | 2026-07-24 | PDF 355.8 KB |
| ID_Label_Location_Info | ID Label/Location Info | 2026-07-24 | PDF 185.3 KB |
| Label_Location | ID Label/Location Info | 2026-07-24 | PDF 360.1 KB |
| Test_Setup_Photos | Test Setup Photos | 2026-07-24 | PDF 535.4 KB |
| Test_Setup_Photos_SAR | Test Setup Photos | 2026-07-24 | PDF 611 KB |
| Test_Setup_Photos_module | Test Setup Photos | 2026-07-24 | PDF 2.1 MB |
| Antenna_information | Test Report | 2026-07-24 | PDF 642.2 KB |
| Test_report_2G4WLAN_end_product_Annex | Test Report | 2026-07-24 | PDF 186.6 KB |
| Test_report_2G4WLAN_end_product_main | Test Report | 2026-07-24 | PDF 2 MB |
| Test_report_2G4WLAN_module_Part2 | Test Report | 2026-07-24 | PDF 3.3 MB |
| Test_report_2G4WLAN_module_Part_1 | Test Report | 2026-07-24 | PDF 5.9 MB |
| Test_report_5GWLAN_end_product_Annex | Test Report | 2026-07-24 | PDF 2.1 MB |
| Test_report_5GWLAN_end_product_main | Test Report | 2026-07-24 | PDF 2.1 MB |
| Test_report_5GWLAN_module_Part_1 | Test Report | 2026-07-24 | PDF 4.4 MB |
| Test_report_5GWLAN_module_Part_2 | Test Report | 2026-07-24 | PDF 6 MB |
| Test_report_5GWLAN_module_Part_3 | Test Report | 2026-07-24 | PDF 6 MB |
| Test_report_5GWLAN_module_Part_4 | Test Report | 2026-07-24 | PDF 987.4 KB |
| Attestation Letter acc. to 2.911(d)(5) | Attestation Statements | 2026-07-24 | PDF 114.6 KB |
| Attestation_Letter_acc._to_2.911(d)(7) | Attestation Statements | 2026-07-24 | PDF 140.3 KB |
| FCC_Confidentiality_Request | Cover Letter(s) | 2026-07-24 | PDF 142.4 KB |
| SAR_Test_Report | RF Exposure Info | 2026-07-24 | PDF 1.2 MB |
| SAR_Test_Report_Caldata | RF Exposure Info | 2026-07-24 | PDF 1.7 MB |
| Block_Diagram Metadata only | Block Diagram | PDF 2.1 MB | |
| Schematics Metadata only | Schematics | PDF 54 KB | |
| Schematics Metadata only | Schematics | PDF 2.5 MB | |
| Schematics(1) Metadata only | Schematics | PDF 2.5 MB | |
| Schematics(1) Metadata only | Schematics | PDF 54 KB | |
| Operational_Description Metadata only | Operational Description | PDF 32.7 KB | |
| Operational_Description_Software_Security Metadata only | Operational Description | PDF 1.3 MB |
Application Information
| Application ID | kSs5j9S59Hnlu7WU5/i7Rw== |
|---|---|
| Final Action Date | 2026-07-24 |
| Application Purpose | Original Equipment |
| Applicant FRN | 0016954943 |
| Model | ACI2PAN9028 |
| Frequency Range | 2412-2462 MHz |
| Equipment Class | DTS - Digital Transmission System |
| Device Description | IVD for monitoring blood glucose. (BGM) |
| Responsible Party | Christian Paulus, christian.paulus@roche.com , +49621759 |
| Non-Technical Contact | Stephanie Hencz, CT CorporationSystem, CTSOPReceipt@wolterskluwer.com , +1 202 572 |
| Test Firm | Gerald Schmidt, cetecom advanced GmbH, tcb@cetecomadvanced.com  , 49-681-598-0 |
| TCB Email | TCB@cetecomadvanced.com |
| TCB Scope | A4: UNII devices & low power transmitters using spread spectrum techniques |
| Short-Term Confidentiality | No |
| Long-Term Confidentiality | Yes |
| Modular Equipment | Does not apply |
| Composite Device | Yes |
| Cognitive Radio | No |
| Authorization Waiver | No |
| Authorization Waiver Approved | No |
| Section 5301 Certification | Yes |
| Related OET Knowledge DataBase Inquiry | No |
Applications
| Application ID | Date | Purpose |
|---|---|---|
| kSs5j9S59Hnlu7WU5/i7Rw== | 2026-07-24 | Original Equipment |
| fPqq6gBLPcFv7M0jiLTPHg== | 2026-07-24 | Original Equipment |
Equipment Authorization
Grants
TCB Grant - Application kSs5j9S59Hnlu7WU5/i7Rw==
| TCB | GRANT OF EQUIPMENT AUTHORIZATION |
TCB |
| Certification | ||
| Issued Under the Authority of the | ||
| Federal Communications Commission | ||
| By: |
|
cetecom advanced GmbH Untertuerkheimer Strasse 6-10 Saarbruecken, 66117 Germany |
Date of Grant: 07/24/2026 Application Dated: 07/23/2026 |
| Roche Diagnostics GmbH |
| Sandhofer Strasse 116 |
| Mannheim, 68305 Germany |
| Attention: Christian Paulus , |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | VO9-ACI2PAN9028 |
| Name of Grantee: | Roche Diagnostics GmbH |
| Equipment Class: | Digital Transmission System |
| Notes: | IVD for monitoring blood glucose. (BGM) |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| CC | 15C | 2412.0 - 2462.0 | 0.18197 |
| Output power listed is peak conducted. This device supports IEEE 802.11b (Wi-Fi 1) with a 20 MHz bandwidth mode, IEEE 802.11g (Wi-Fi 3) with a 20 MHz bandwidth mode and IEEE 802.11n (Wi-Fi 4) with a 20 MHz and 40 MHz bandwidth mode. This device has been tested touched to the phantom and meets FCC RF exposure guidelines. The highest reported SAR for body-worn and extremities SAR exposure conditions are 0.640 W/kg and 0.293 W/kg, respectively. |
| CC: | This device is certified pursuant to two different Part 15 rules sections. |
TCB Grant - Application fPqq6gBLPcFv7M0jiLTPHg==
| TCB | GRANT OF EQUIPMENT AUTHORIZATION |
TCB |
| Certification | ||
| Issued Under the Authority of the | ||
| Federal Communications Commission | ||
| By: |
|
cetecom advanced GmbH Untertuerkheimer Strasse 6-10 Saarbruecken, 66117 Germany |
Date of Grant: 07/24/2026 Application Dated: 07/23/2026 |
| Roche Diagnostics GmbH |
| Sandhofer Strasse 116 |
| Mannheim, 68305 Germany |
| Attention: Christian Paulus , |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | VO9-ACI2PAN9028 |
| Name of Grantee: | Roche Diagnostics GmbH |
| Equipment Class: | Unlicensed National Information Infrastructure TX |
| Notes: | IVD for monitoring blood glucose. (BGM) |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| CC | 15E | 5180.0 - 5240.0 | 0.02042 |
| Output power listed is average conducted. This device supports IEEE 802.11a (Wi-Fi 2) with a 20 MHz bandwidth mode, IEEE 802.11n (Wi-Fi 3) with a 20 MHz and 40 MHz bandwidth mode and IEEE 802.11ac (Wi-Fi 5) with a 20 MHz, 40 MHz and 80 MHz bandwidth mode. This device has been tested touched to the phantom and meets FCC RF exposure guidelines. The highest reported SAR for body-worn and extremities SAR exposure conditions are 1.127 W/kg and 0.389 W/kg, respectively. |
| CC: | This device is certified pursuant to two different Part 15 rules sections. |